Related Experiment Videos
A cholesterol biosynthesis inhibitor from Rhizopus oryzae
Hyun Jung Kim1, Soon-Ho Yim, Ik-Soo Lee
1College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Korea.
Archives of Pharmacal Research
|July 31, 2004
Summary
Methyl cholate, a bile acid derivative from fungus, inhibits cholesterol biosynthesis in liver cells. Its mechanism differs from statins, targeting later stages of the pathway.
Area of Science:
- Biochemistry
- Mycology
- Pharmacology
Background:
- Cholesterol biosynthesis is a critical metabolic pathway.
- Statins are widely used cholesterol-lowering drugs targeting HMG-CoA reductase.
- Novel inhibitors with different mechanisms are needed for cholesterol management.
Purpose of the Study:
- To isolate and identify cholesterol biosynthesis inhibitors from fungal extracts.
- To investigate the inhibitory activity and mechanism of methyl cholate on cholesterol biosynthesis.
Main Methods:
- Extraction and isolation of compounds from Rhizopus oryzae.
- Assay of cholesterol biosynthesis inhibition in human Chang liver cells.
- Determination of the specific step inhibited in the cholesterol biosynthesis pathway.
Main Results:
- Methyl cholate was isolated from the EtOAc extract of Rhizopus oryzae.
- Compound 1 demonstrated moderate inhibitory activity against cholesterol biosynthesis.
- Methyl cholate inhibited a later step in cholesterol biosynthesis, distinct from HMG-CoA reductase.
Conclusions:
- Methyl cholate is a novel cholesterol biosynthesis inhibitor.
- Its mechanism of action differs from that of statins.
- This bile acid derivative warrants further investigation for therapeutic potential.